Skip to main content
IDF logo
dna strand

The immune system and genetics

Primary immunodeficiencies can be inherited in one of three different ways depending on the specific disorder: X-linked recessive, autosomal recessive, or autosomal dominant.

How genetics works

Each cell in the human body contains genetic material that carries the instructions for every protein, cell, and organ that makes up the body. This "master plan" genetic material is packaged into 23 pairs of chromosomes, for 46 total chromosomes. There are 22 pairs of numbered chromosomes (also known as autosomes), and one pair of sex chromosomes (XX for females and XY for males). Children inherit one chromosome in each pair from their mother and one chromosome in each pair from their father.

Children inherit one set of 22 autosomes from their biological mother and one set of 22 autosomes from their biological father.

During fertilization, the egg, which contains 23 single chromosomes, fuses with the sperm, which also contains 23 single chromosomes, and the resulting fetus has 46 total chromosomes. This way, each parent contributes half of the genetic information for their child. The sex of the child is determined by which sex chromosome (X or Y) the sperm that fuses with the egg (only X) carries. An X chromosome from the sperm results in a female offspring and a Y chromosome from the sperm results in a male offspring.

People who are genetically female have two copies of the X chromosome, one from their biological mother and one from their biological father. People who are genetically male have one copy of the X chromosome from their biological mother and one copy of the Y chromosome from their biological father.

The genetic material packaged in these chromosomes is made up of deoxyribonucleic acid (DNA), which is composed of individual molecules called nucleotides. Four nucleotides make up DNA: adenine (A), thymidine (T), guanine (G), and cytosine (C). The order of these nucleotides, or the DNA "sequence," encodes information in long chains that are arranged in a specific way, similar to the arrangement of letters to form words and sentences.

Variants in the spelling of the words (because of misplacement of one or more nucleotides) lead to genetic differences between people. Some spelling variants might not lead to a significant change in the genetic instructions, and those variants do not cause disease. Other spelling variants do significantly change the instructions, and those types of variants can cause diseases such as PI.

If these gene variants are passed down in the egg or sperm of one or both parents, they can cause disease in the child. Occasionally, variants spontaneously occur in a fertilized egg, and neither of the parents actually carry the variant.

Types of inheritance

PI can be inherited in one of three different ways: autosomal recessive, autosomal dominant, or X-linked recessive. Family history and genetic testing can be helpful in establishing the possible role of genes or chromosomes in a particular PI and may be useful to identify a particular pattern of inheritance.

Genes present on one of the 22 pairs of numbered chromosomes are known as autosomal. In autosomal recessive inheritance, two copies of the PI-causing gene variant must be inherited to cause symptoms of the condition, typically one from each parent.

Usually, each parent of the child affected by an autosomal recessive condition carries one copy of the PI-causing gene variant, and they are unaffected because their other copy of the gene is functional. In this scenario, where both parents are carriers of an autosomal recessive gene variant, there is a 25% chance (1 in 4) that any child, regardless of gender, will be affected by the disorder. There is a 50% chance (1 in 2) that any child will be a carrier (inherit one copy of the variant), and a 25% (1 in 4) that the child will not inherit the at all, and therefore will not be affected by the condition or be able to pass it on to their children.

The chances of a child being affected, a carrier, or neither remain the same for all future pregnancies. The outcome of each pregnancy is independent and is not affected by previous pregnancies.

Examples of autosomal recessive PIs:

Autosomal recessive PIs are rare. Most affected infants do not have any previous family history. However, marriages between people who are related by blood or increased frequency of specific variants in certain populations (such as the Artemis SCID variant in Navajo populations) increase the incidence of such conditions.

Autosomal dominant inheritance is a mode of inheritance where only one copy of the PI-causing gene variant is needed for the disease to occur, regardless of the version of the gene inherited from the other parent. Both males and females can be affected, and there is a 50% chance (1 in 2) of the child of an affected parent inheriting the disease. The risk is the same in every pregnancy.

Sometimes, a patient affected with an autosomal dominant condition will be the first affected person in their family. In this case, the variant spontaneously occurs in the fertilized egg after the joining of egg and sperm.

Examples of autosomal dominant PIs:

X-linked recessive is a mode of inheritance where the gene variant causing PI is present on the X chromosome. Because males have only one X chromosome, if that X chromosome carries the gene variant, the individual will be affected by the PI. Males have no additional X chromosome to compensate and the Y chromosome does not carry the same set of genes as the X chromosome.

Females have two X chromosomes and must inherit two copies of the gene variant—one from each parent—to develop the disorder. Females are carriers if they inherit one variant because the second copy of the X-linked gene continues to carry out its function. Carriers can pass on the gene variant to their children.

An affected male will pass on the gene variant to 100% of his female children because they will all inherit his X chromosome. In most cases, his daughters will be carriers, unless their mother also happens to be a carrier—then, there is a 50% chance of each daughter being affected.

All of an affected male’s sons will carry the Y chromosome and will therefore neither be affected nor be carriers.

At times, female carriers of X-linked disorders do present with symptoms similar to affected males due to a process called X-inactivation. In this process, which happens during fetal development, some cells shut down (inactivate) the X chromosome inherited from the mother, and other cells inactivate the X chromosome inherited from the father. Which X chromosome each cell inactivates is random.

In the case of an X-linked carrier, if the inactivation happened to the X chromosome coming from the mother, then the only active chromosome will be the X chromosome coming from the father, which carries the disease-causing variant, leading to symptoms similar to the affected males.

Mothers who are carriers can pass on the disease to their sons if the sons inherit the affected X. In this type of inheritance, a family history may show multiple males affected by the disease. Mothers who are carriers can also pass on the affected X to their daughters, who then become carriers of the disease themselves.

Variants in X chromosome genes may also occur spontaneously and may occur in individuals with no previous family history.

Examples of X-linked recessive PIs:

The chances of a woman who carries a PI-causing X-linked gene variant having an affected child are different based on the gender of the child. If the father is not affected, there are four possible combinations in every pregnancy.

  • 25% chance (1 in 4) that a son will inherit the Y chromosome from his father and X-linked recessive gene variant from his mother. He will, therefore, be affected.
  • 25% chance (1 in 4) that a son will inherit the Y chromosome from his father and the working copy of the X-linked gene from his mother. He will not be affected by the condition.
  • 25% chance (1 in 4) that a daughter will inherit both working copies of the X-linked genes: one copy from her father and one from her mother. In this case, she will not only be unaffected by the condition, but she will also not be a carrier of the X-linked recessive gene variant.
  • 25% chance (1 in 4) that a daughter will inherit from her father the working copy of the X-linked gene and the faulty X-linked recessive gene variant from her mother. She will be a carrier of the condition like her mother and will usually be unaffected.

The outcome of future pregnancies is not affected by previous pregnancies, meaning that it is possible for all (100%) of the boys in a family where the mother is a carrier to be affected by the X-linked condition.

Carrier testing

With increasingly well-defined immunodeficiencies, DNA analysis can be performed to identify the presence of a gene variant not only in affected individuals but in their unaffected family members. In cases of a family history of autosomal recessive or X-linked recessive PI, DNA samples from family members can be analyzed to establish if they are carriers or not. Prospective parents should seek out information from healthcare professionals such as pediatricians, genetic counselors, immunologists, and obstetricians on current medical advances relating to the PI of concern. Genetic counseling is highly recommended in families with a known history of PI, as it allows the option for early detection, diagnosis, and treatment.

In cases that do not fit a typical pattern or where initial genetic testing does not lead to a diagnosis, there are now other advanced techniques that may identify the underlying genetic cause. These all use next-generation sequencing (NGS) methods:

  • Whole genome sequencing (WGS) involves reading an individual's entire DNA sequence.
  • Whole exome sequencing (WES) involves reading the sequences of all the protein-coding genes.
  • NGS panels sequence a particular group of genes.

These techniques allow precise diagnosis in increasing numbers of families. Consult with your physician or genetic counselor to learn if carrier detection is available in your specific situation.

Prenatal diagnosis

It is undeniable that raising a child with PI places a physical, emotional, and financial burden on families, and many families might wish to maintain their current family size to avoid the possibility of having another affected child. Those choices are very personal.

In families with a PI, some parents may wish to know whether future babies are affected by the disorder. Testing to determine whether unborn babies are affected is possible in most situations where the immunodeficiency has a known genetic cause, such as XLA or RAG1 SCID. However, prenatal testing is only possible if the genetic cause has been defined for an immunodeficiency. There are several methods of prenatal diagnosis for PI.

DNA from the fetus can be obtained by CVS or amniocentesis. These procedures can obtain a fetal sample for chromosome, genetic, or biochemical testing. CVS is usually scheduled at 10-13 weeks of pregnancy and involves the retrieval of a tiny sample of the developing placenta from the womb. Amniocentesis is typically performed at 16-17 weeks of pregnancy and involves the withdrawal of amniotic fluid containing fetal cells. Both procedures have a small risk of miscarriage that should be balanced against the benefits of the testing.

Several types of analysis can be done with CVS or amniocentesis samples:

  1. Gene variant analysis: This method is 100% reliable if the PI-causing variant is known.
  2. Linkage analysis: If the PI-causing variant is unknown, but the diagnosis is definite, prenatal diagnosis may be possible using linkage analysis. This will be slightly less reliable than gene variant detection.
  3. Enzyme analysis: The concentration and/or function of the enzyme that is known to be affected in a certain PI can be measured. Examples are adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP), deficiencies which both cause forms of SCID. Both of these enzymes can be analyzed in a CVS sample taken at 11-12 weeks of gestation.

Noninvasive prenatal testing (NIPT), sometimes called noninvasive prenatal screening (NIPS), is a method of analyzing small fragments of DNA that are circulating in a pregnant woman’s blood. Unlike most DNA, which is found inside a cell’s nucleus, these small DNA fragments are free-floating and not within cells, and so are called cell-free DNA (cfDNA). These small fragments usually contain fewer than 200 nucleotides and arise when cells die off and get broken down and their contents, including DNA, are released into the bloodstream. NIPT involves taking a blood sample from the mother and is not associated with any risk of miscarriage.

During pregnancy, the mother’s blood contains a mix of cfDNA that comes from her cells and cells from the placenta. The placenta is tissue in the uterus that links the fetus and the mother’s blood supply. The DNA in placental cells is usually identical to the DNA of the fetus. Analyzing cfDNA from the placenta provides an opportunity for early detection of certain genetic abnormalities without harming the fetus.

NIPT is a screening test, which means that it will not give a definitive answer about whether or not a fetus has a genetic condition. The test can only estimate whether the risk of having certain conditions is increased or decreased. In some cases, NIPT results indicate an increased risk for a genetic condition when the fetus is actually unaffected (false positive), or the results indicate a decreased risk for a genetic condition when the fetus is actually affected (false negative). Because NIPT analyzes both fetal and maternal cfDNA, the test may detect a genetic condition in the mother.

Pre-implantation genetic diagnosis (PGD) is a useful option for couples who are at high risk of bearing a child with a single gene disorder. It involves in vitro fertilization (IVF) of a number of eggs, followed by genetic testing of a single cell from each embryo, and subsequent implantation of 1-3 embryos that do not have the PI-causing variant.

Implantation of an unaffected embryo via IVF in individuals with SCID, LAD, CGD, and XLA has been previously reported. Evidence also supports the efficacy of PGD in the detection of other immunodeficiencies such as Wiskott-Aldrich syndrome, X-linked hyper IgM syndrome (HIGM), X-linked hypohidrotic ectodermal dysplasia with immune deficiency (HED-ID), and ataxia-telangiectasia.

Gamete donation (use of donor egg or sperm) to conceive a child via IVF for infertile couples can be associated with a risk of inheritable forms of PI, particularly if the health status of the donor with regard to immunodeficiency has not been established.

This page contains general medical and/or legal information that cannot be applied safely to any individual case. Medical and/or legal knowledge and practice can change rapidly. Therefore, this page should not be used as a substitute for professional medical and/or legal advice. Additionally, links to other resources and websites are shared for informational purposes only and should not be considered an endorsement by the Immune Deficiency Foundation.

Adapted from the IDF Patient & Family Handbook for Primary Immunodeficiency Diseases, Sixth Edition 
Copyright ©2019 by Immune Deficiency Foundation, USA